Symbols / SRZN $33.03 +6.21% Surrozen, Inc.

Healthcare • Biotechnology • United States • NCM
SRZN Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Fundamentals
Scroll to Statements
Market Cap 388.52M Enterprise Value 296.80M Income -242.03M Sales 3.48M Book/sh -19.21 Cash/sh 7.77
Dividend Yield — Payout 0.00% Employees 44 IPO — P/E — Forward P/E -9.27
PEG — P/S 111.74 P/B -1.72 P/C — EV/EBITDA -7.14 EV/Sales 85.36
Quick Ratio 9.01 Current Ratio 9.22 Debt/Eq — LT Debt/Eq — EPS (ttm) -32.37 EPS next Y -3.56
EPS Growth — Revenue Growth -19.40% Earnings 2026-03-23 ROA -35.75% ROE — ROIC —
Gross Margin 0.00% Oper. Margin -23.94% Profit Margin 0.00% Shs Outstand 11.76M Shs Float 5.42M Short Float 5.52%
Short Ratio 3.73 Short Interest — 52W High 33.96 52W Low 5.90 Beta 0.52 Avg Volume 121.29K
Volume 218.49K Target Price $38.75 Recom None Prev Close $31.10 Price $33.03 Change 6.21%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$38.75
Mean price target
2. Current target
$33.03
Latest analyst target
3. DCF / Fair value
$-25.80
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$33.03
Low
$36.00
High
$42.00
Mean
$38.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-21 init TD Cowen — → Buy —
2026-03-24 reit Cantor Fitzgerald Overweight → Overweight $40
2026-03-24 reit HC Wainwright & Co. Buy → Buy $36
2026-02-19 init Cantor Fitzgerald — → Overweight $40
2025-05-12 reit HC Wainwright & Co. Buy → Buy $32
2025-04-02 reit HC Wainwright & Co. Buy → Buy $32
2025-01-30 init HC Wainwright & Co. — → Buy $32
2025-01-03 up Guggenheim Neutral → Buy $45
News
RSS: Latest SRZN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 LI YANG Officer — 1,666 $0.00 $0
2026-03-24 TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security — 121,881 $24.69 $3,012,768
2026-03-16 TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security — 48,997 $24.88 $1,220,362
2026-02-12 TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security — 18,856 $23.58 $444,844
2026-02-03 TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security — 9,357 $21.38 $202,534
2026-01-20 COLUMN GROUP III GP, L.P Beneficial Owner of more than 10% of a Class of Security — 32,507 $19.60 $641,597
2026-01-20 KUTZKEY TIM PH.D. Director and Beneficial Owner of more than 10% of a Class of Security — 32,507 $19.60 $641,597
2026-01-14 COLUMN GROUP III GP, L.P Beneficial Owner of more than 10% of a Class of Security — 17,993 $19.80 $357,353
2026-01-14 KUTZKEY TIM PH.D. Director and Beneficial Owner of more than 10% of a Class of Security — 17,993 $19.80 $357,353
2026-01-06 COLUMN GROUP III GP, L.P Beneficial Owner of more than 10% of a Class of Security — 15,100 $19.89 $300,297
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3.48
-67.37%
10.65
0.00
-100.00%
12.50
Operating Revenue
3.48
-67.37%
10.65
0.00
-100.00%
12.50
Operating Expense
45.57
+25.90%
36.19
-15.88%
43.03
-24.30%
56.84
Research And Development
29.36
+38.96%
21.13
-22.39%
27.23
-26.43%
37.01
Selling General And Administration
16.20
+7.58%
15.06
-4.66%
15.80
-20.32%
19.83
General And Administrative Expense
16.20
+7.58%
15.06
-4.66%
15.80
-20.32%
19.83
Other Gand A
16.20
+7.58%
15.06
-4.66%
15.80
-20.32%
19.83
Total Expenses
45.57
+25.90%
36.19
-15.88%
43.03
-24.30%
56.84
Operating Income
-42.09
-64.81%
-25.54
+40.65%
-43.03
+2.96%
-44.34
Total Operating Income As Reported
-42.09
-64.81%
-25.54
+44.21%
-45.78
-3.25%
-44.34
EBITDA
-41.55
-72.45%
-24.10
+41.39%
-41.12
+2.99%
-42.38
Normalized EBITDA
135.09
+660.60%
-24.10
+37.19%
-38.37
+9.48%
-42.38
Reconciled Depreciation
0.54
-62.76%
1.44
-24.54%
1.91
-2.25%
1.96
EBIT
-42.09
-64.81%
-25.54
+40.65%
-43.03
+2.96%
-44.34
Total Unusual Items
-176.64
0.00
+100.00%
-2.75
0.00
Total Unusual Items Excluding Goodwill
-176.64
0.00
+100.00%
-2.75
0.00
Special Income Charges
—
0.00
+100.00%
-2.75
0.00
Restructuring And Mergern Acquisition
—
0.00
-100.00%
2.75
0.00
Net Income
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Pretax Income
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Net Non Operating Interest Income Expense
3.02
+78.38%
1.69
-27.65%
2.34
+199.62%
0.78
Net Interest Income
3.02
+78.38%
1.69
-27.65%
2.34
+199.62%
0.78
Interest Income Non Operating
3.02
+78.38%
1.69
-27.65%
2.34
+199.62%
0.78
Interest Income
3.02
+78.38%
1.69
-27.65%
2.34
+199.62%
0.78
Other Income Expense
-202.95
-410.99%
-39.72
-1587.26%
-2.35
-131.16%
7.55
Other Non Operating Income Expenses
-26.31
+33.75%
-39.72
-10079.40%
0.40
-94.73%
7.55
Gain On Sale Of Security
-176.64
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Net Income From Continuing Operation Net Minority Interest
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Net Income From Continuing And Discontinued Operation
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Net Income Continuous Operations
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Normalized Income
-65.38
-2.86%
-63.56
-57.77%
-40.29
-11.90%
-36.00
Net Income Common Stockholders
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Diluted EPS
-32.37
-49.38%
-21.67
-1.59%
-21.33
-36.73%
-15.60
Basic EPS
-32.37
-49.38%
-21.67
-1.59%
-21.33
-36.73%
-15.60
Basic Average Shares
7.48
+154.96%
2.93
+45.34%
2.02
-12.82%
2.31
Diluted Average Shares
7.48
+154.96%
2.93
+45.34%
2.02
-12.82%
2.31
Diluted NI Availto Com Stockholders
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
98.73
+103.70%
48.47
+5.18%
46.08
-48.48%
89.44
Current Assets
91.56
+135.18%
38.93
-5.35%
41.13
-49.41%
81.31
Cash Cash Equivalents And Short Term Investments
89.25
+158.19%
34.56
-4.10%
36.04
-52.47%
75.84
Cash And Cash Equivalents
89.25
+158.19%
34.56
-4.10%
36.04
+45.98%
24.69
Other Short Term Investments
—
—
0.00
-100.00%
51.15
Receivables
0.21
-91.81%
2.54
+18.08%
2.15
+8.80%
1.98
Accounts Receivable
0.00
-100.00%
2.04
-5.25%
2.15
+8.80%
1.98
Prepaid Assets
2.11
+15.33%
1.83
-22.53%
2.36
-13.76%
2.73
Other Current Assets
—
0.67
+15.69%
0.58
-23.28%
0.76
Total Non Current Assets
7.17
-24.83%
9.54
+92.70%
4.95
-39.14%
8.13
Net PPE
6.43
-23.08%
8.36
+116.77%
3.86
-44.07%
6.90
Gross PPE
14.81
-8.65%
16.21
+44.40%
11.23
-38.50%
18.25
Accumulated Depreciation
-8.38
-6.73%
-7.85
-6.50%
-7.37
+35.11%
-11.36
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
—
—
3.27
Machinery Furniture Equipment
0.52
+0.00%
0.52
-0.39%
0.52
+23.92%
0.42
Other Properties
13.18
-9.62%
14.58
+51.98%
9.59
-11.05%
10.78
Leases
1.12
+0.00%
1.12
+0.00%
1.12
-84.17%
7.05
Investments And Advances
—
—
—
0.00
Other Non Current Assets
0.73
-27.97%
1.02
-6.51%
1.09
-11.53%
1.23
Total Liabilities Net Minority Interest
286.49
+310.17%
69.85
+757.54%
8.14
-39.37%
13.43
Current Liabilities
9.93
+35.75%
7.32
+2.34%
7.15
-26.55%
9.73
Payables And Accrued Expenses
8.35
+57.71%
5.29
+21.47%
4.36
-37.05%
6.92
Payables
0.73
+137.91%
0.31
-41.71%
0.53
-20.21%
0.66
Accounts Payable
0.73
+137.91%
0.31
-41.71%
0.53
-20.21%
0.66
Current Accrued Expenses
7.62
+52.80%
4.99
+30.13%
3.83
-38.82%
6.27
Current Debt And Capital Lease Obligation
1.29
-29.47%
1.83
-26.75%
2.50
+12.17%
2.23
Current Capital Lease Obligation
1.29
-29.47%
1.83
-26.75%
2.50
+12.17%
2.23
Other Current Liabilities
0.29
+51.31%
0.19
-34.59%
0.29
-49.74%
0.58
Total Non Current Liabilities Net Minority Interest
276.56
+342.27%
62.53
+6172.02%
1.00
-73.07%
3.70
Long Term Debt And Capital Lease Obligation
5.35
-19.44%
6.64
+652.83%
0.88
-73.87%
3.38
Long Term Capital Lease Obligation
5.35
-19.44%
6.64
+652.83%
0.88
-73.87%
3.38
Other Non Current Liabilities
158.66
—
—
—
Stockholders Equity
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Common Stock Equity
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
9.77
+199.65%
3.26
+58.12%
2.06
+2.85%
2.01
Ordinary Shares Number
9.77
+199.65%
3.26
+58.12%
2.06
+2.85%
2.01
Additional Paid In Capital
339.52
+28.67%
263.88
+1.64%
259.63
+1.86%
254.90
Retained Earnings
-527.28
-84.84%
-285.26
-28.67%
-221.69
-24.09%
-178.65
Gains Losses Not Affecting Retained Earnings
—
—
0.00
+100.00%
-0.24
Other Equity Adjustments
—
—
—
-0.24
Total Equity Gross Minority Interest
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Total Capitalization
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Working Capital
81.63
+158.18%
31.62
-6.97%
33.98
-52.52%
71.57
Invested Capital
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Total Debt
6.64
-21.61%
8.47
+150.64%
3.38
-39.68%
5.60
Capital Lease Obligations
6.64
-21.61%
8.47
+150.64%
3.38
-39.68%
5.60
Net Tangible Assets
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Tangible Book Value
-187.76
-778.21%
-21.38
-156.36%
37.94
-50.09%
76.00
Available For Sale Securities
—
—
—
—
Derivative Product Liabilities
112.55
+101.37%
55.89
+48501.74%
0.12
-64.72%
0.33
Duefrom Related Parties Current
0.21
-58.57%
0.50
0.00
—
Financial Assets
0.00
-100.00%
0.15
0.00
—
Investmentin Financial Assets
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-30.24
-71.57%
-17.63
+56.33%
-40.36
+8.57%
-44.15
Cash Flow From Continuing Operating Activities
-30.24
-71.57%
-17.63
+56.33%
-40.36
+8.57%
-44.15
Net Income From Continuing Operations
-242.03
-280.76%
-63.56
-47.68%
-43.04
-19.55%
-36.00
Depreciation Amortization Depletion
0.54
-62.76%
1.44
-24.54%
1.91
-2.25%
1.96
Depreciation
—
—
1.91
-2.25%
1.96
Depreciation And Amortization
0.54
-62.76%
1.44
-24.54%
1.91
-2.25%
1.96
Other Non Cash Items
72.12
+5167.79%
1.37
+7.54%
1.27
-19.79%
1.59
Stock Based Compensation
3.83
-6.78%
4.11
-5.90%
4.37
-3.21%
4.52
Asset Impairment Charge
0.92
0.00
-100.00%
0.17
0.00
Operating Gains Losses
131.22
+229.31%
39.85
+10449.87%
-0.39
+95.12%
-7.89
Gain Loss On Investment Securities
131.22
+230.24%
39.73
+18931.28%
-0.21
+97.33%
-7.89
Net Foreign Currency Exchange Gain Loss
0.00
-100.00%
0.11
+164.94%
-0.17
—
Change In Working Capital
3.15
+477.15%
-0.84
+78.72%
-3.93
+53.33%
-8.42
Change In Receivables
2.33
+564.74%
-0.50
0.00
+100.00%
-1.98
Changes In Account Receivables
2.33
+564.74%
-0.50
0.00
+100.00%
-1.98
Change In Prepaid Assets
-0.07
-106.03%
1.11
+21.42%
0.92
+1930.00%
-0.05
Change In Payables And Accrued Expense
2.65
+219.44%
0.83
+130.86%
-2.68
+29.76%
-3.82
Change In Accrued Expense
2.50
+137.03%
1.06
+141.41%
-2.55
-43.10%
-1.78
Change In Payable
0.14
+162.28%
-0.23
-71.43%
-0.13
+93.47%
-2.04
Change In Account Payable
0.14
+162.28%
-0.23
-71.43%
-0.13
+93.47%
-2.04
Change In Other Current Assets
0.07
+1.41%
0.07
+14.52%
0.06
+116.36%
-0.38
Change In Other Current Liabilities
-1.83
+21.93%
-2.34
-5.44%
-2.22
-1.46%
-2.19
Investing Cash Flow
-0.13
-392.31%
-0.03
-100.05%
51.72
+35.02%
38.31
Cash Flow From Continuing Investing Activities
-0.13
-392.31%
-0.03
-100.05%
51.72
+35.02%
38.31
Net PPE Purchase And Sale
-0.13
-392.31%
-0.03
+93.47%
-0.40
+45.33%
-0.73
Purchase Of PPE
-0.13
-392.31%
-0.03
+93.47%
-0.40
+45.33%
-0.73
Capital Expenditure
-0.13
-392.31%
-0.03
+93.47%
-0.40
+45.33%
-0.73
Net Investment Purchase And Sale
—
0.00
-100.00%
52.12
+33.52%
39.04
Purchase Of Investment
—
0.00
+100.00%
-28.04
+5.26%
-29.60
Sale Of Investment
—
0.00
-100.00%
80.17
+16.80%
68.64
Financing Cash Flow
85.05
+425.79%
16.18
+5760.87%
0.28
+110.76%
-2.56
Cash Flow From Continuing Financing Activities
85.05
+425.79%
16.18
+5760.87%
0.28
+110.76%
-2.56
Net Common Stock Issuance
83.78
+422.22%
16.04
+401175.00%
-0.00
+99.85%
-2.61
Common Stock Payments
—
0.00
+100.00%
-0.00
+99.85%
-2.61
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.00
+99.85%
-2.61
Proceeds From Stock Option Exercised
1.27
+856.39%
0.13
-52.50%
0.28
+566.67%
0.04
Net Other Financing Charges
—
—
—
-0.10
Changes In Cash
54.68
+3799.59%
-1.48
-112.70%
11.64
+238.51%
-8.40
Beginning Cash Position
35.25
-4.02%
36.73
+46.37%
25.09
-25.08%
33.50
End Cash Position
89.93
+155.11%
35.25
-4.02%
36.73
+46.37%
25.09
Free Cash Flow
-30.37
-72.04%
-17.65
+56.69%
-40.76
+9.16%
-44.87
Amortization Of Securities
—
0.00
+100.00%
-0.73
-777.78%
0.11
Common Stock Issuance
83.78
+422.22%
16.04
0.00
0.00
Issuance Of Capital Stock
83.78
+422.22%
16.04
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category